{"id":18110,"date":"2016-03-04T00:00:00","date_gmt":"2016-03-04T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/2016\/03\/04\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"},"modified":"2024-04-24T19:50:22","modified_gmt":"2024-04-24T19:50:22","slug":"eyewitness-report-fda-science-board-meets-on-opioid-crisis","status":"publish","type":"post","link":"https:\/\/www.cadca.org\/es\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","title":{"rendered":"Informe de un testigo presencial: La Junta Cient\u00edfica de la FDA se re\u00fane sobre la crisis de los opioides"},"content":{"rendered":"<p>El reci\u00e9n nombrado <a href=\"https:\/\/www.fda.gov\/AboutFDA\/CommissionersPage\/default.htm\" target=\"_blank\" rel=\"noopener\">Comisionado de la FDA, Robert M. Califf, MD<\/a>., ha hecho que abordar la crisis de opioides sea una prioridad. El 4 de febrero, mientras muchos miembros de CADCA estaban finalizando su capacitaci\u00f3n en el Foro Nacional de Liderazgo de CADCA, el <a href=\"https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm484765.htm\" target=\"_blank\" rel=\"noopener\">La FDA anunci\u00f3 un plan de acci\u00f3n<\/a> para reevaluar el enfoque de la agencia hacia los medicamentos opioides.\u00a0<\/p>\n<p>Inmediatamente despu\u00e9s de este amplio anuncio, la FDA program\u00f3 una reuni\u00f3n de su Junta Cient\u00edfica para el 1 de marzo. Los objetivos de la discusi\u00f3n fueron los siguientes: discutir el papel de los opioides en el manejo del dolor; considerar el desarrollo de nuevos medicamentos para tratar el dolor que reduzcan el riesgo de abuso; y explorar el papel que desempe\u00f1a la FDA como parte de una respuesta federal, estatal y local m\u00e1s amplia a los desaf\u00edos de brindar un tratamiento adecuado para el dolor y al mismo tiempo reducir el abuso de medicamentos opioides recetados. Si tiene un poco de experto en pol\u00edticas, aqu\u00ed tiene algunas <a href=\"https:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/ScienceBoardtotheFoodandDrugAdministration\/ucm487037.htm\" target=\"_blank\" rel=\"noopener\">materiales de fondo<\/a> la FDA recopil\u00f3 que usted puede disfrutar leyendo.<\/p>\n<p>Fui testigo presencial de esta reuni\u00f3n. Una de las grandes oportunidades que tenemos en CADCA es representar el campo de la coalici\u00f3n en momentos como este. No sorprende que la reuni\u00f3n de expertos m\u00e9dicos centrara la mayor parte de su atenci\u00f3n en las soluciones farmacol\u00f3gicas. Se afirm\u00f3 que la FDA no regula a la comunidad m\u00e9dica. Sin embargo, tienen una enorme influencia sobre el etiquetado, los nuevos productos, las formaciones disuasorias del abuso y la Estrategia de Evaluaci\u00f3n y Mitigaci\u00f3n de Riesgos (REMS), que exigen que los fabricantes garanticen que los beneficios de un medicamento o producto biol\u00f3gico superen sus riesgos.<\/p>\n<p>La primera parte del d\u00eda consisti\u00f3 en presentaciones de varios oradores de alto nivel sobre pol\u00edticas, dolor, adicci\u00f3n y datos. Por la tarde hubo tiempo para comentarios p\u00fablicos. Durante m\u00e1s de una hora y media, la junta cient\u00edfica y los l\u00edderes de la FDA escucharon a una amplia gama de ciudadanos estadounidenses y, curiosamente, a un franc\u00e9s. Lo m\u00e1s conmovedor para m\u00ed fue la declaraci\u00f3n de Don Flattery, un padre que perdi\u00f3 a su hijo de 27 a\u00f1os a causa de la enfermedad de la adicci\u00f3n, y se\u00f1al\u00f3 la exposici\u00f3n temprana de su hijo a los opioides como resultado de una lesi\u00f3n deportiva. La Junta escuch\u00f3 a un defensor de pacientes con un trastorno poco com\u00fan del tejido conectivo que enfatiz\u00f3 la necesidad de acceso a opioides para ayudarla en su funcionamiento diario. Se escucharon comentarios de representantes de la industria, defensores apasionados (tanto del lado del dolor como de la adicci\u00f3n) e incluso de un fabricante de un dispositivo m\u00e9dico que promet\u00eda distribuir dosis de opioides de forma segura. El per\u00edodo de comentarios p\u00fablicos represent\u00f3 un grupo muy diverso de ideas y subray\u00f3 la complejidad de los problemas que enfrentamos.<\/p>\n<p>En DC es raro ver a un senador estadounidense frente al Capitolio. As\u00ed que me emocion\u00f3 ver que el senador Joe Manchin de Virginia Occidental cruz\u00f3 la ciudad para compartir una <a href=\"https:\/\/www.manchin.senate.gov\/public\/index.cfm\/press-releases?ID=22FCD76D-DF4A-4425-B858-79C88DCAEDD6\" target=\"_blank\" rel=\"noopener\">declaraci\u00f3n<\/a> durante el tiempo de comentarios p\u00fablicos tambi\u00e9n.\u00a0<\/p>\n<p>Cada d\u00eda, 44 personas en Estados Unidos mueren por sobredosis de opi\u00e1ceos recetados. Los defensores locales de CADCA han estado actuando, no esperando. Las coaliciones est\u00e1n educando a los j\u00f3venes y a los padres sobre los riesgos, involucrando a los prescriptores sobre sus pr\u00e1cticas, apoyando a los PDMP, organizando jornadas de recuperaci\u00f3n con las autoridades, trabajando en las escuelas para brindar educaci\u00f3n sobre la seguridad de los medicamentos y mucho m\u00e1s. Algunos de los desaf\u00edos deben enfrentarse a nivel estatal y federal. La FDA tiene tanto la autoridad como las relaciones para lograr un impacto monumental. CADCA se compromete a realizar un seguimiento de todas las acciones federales relacionadas con nuestra crisis de opioides y a mantener el campo actualizado.\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>El reci\u00e9n nombrado Comisionado de la FDA, Dr. Robert M. Califf, ha hecho de abordar la crisis de opioides una prioridad. El 4 de febrero<\/p>","protected":false},"author":23,"featured_media":2408,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[360],"tags":[221],"class_list":["post-18110","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-public-health","tag-opioids"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA<\/title>\n<meta name=\"description\" content=\"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/es\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA\" \/>\n<meta property=\"og:description\" content=\"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/es\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-04T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-24T19:50:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"426\" \/>\n\t<meta property=\"og:image:height\" content=\"320\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marianne Varkiani\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marianne Varkiani\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\"},\"author\":{\"name\":\"Marianne Varkiani\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#\\\/schema\\\/person\\\/8e6cb67aa13c20300a849b431c929dd2\"},\"headline\":\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis\",\"datePublished\":\"2016-03-04T00:00:00+00:00\",\"dateModified\":\"2024-04-24T19:50:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\"},\"wordCount\":575,\"image\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"keywords\":[\"opioids\"],\"articleSection\":[\"Public Health\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\",\"name\":\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"datePublished\":\"2016-03-04T00:00:00+00:00\",\"dateModified\":\"2024-04-24T19:50:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#\\\/schema\\\/person\\\/8e6cb67aa13c20300a849b431c929dd2\"},\"description\":\"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cdc-us-overdose-deaths-2014_jr-1.jpg\",\"width\":426,\"height\":320},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/public-health\\\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eyewitness Report: FDA Science Board Meets on Opioid Crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#\\\/schema\\\/person\\\/8e6cb67aa13c20300a849b431c929dd2\",\"name\":\"Marianne Varkiani\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA","description":"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/es\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","og_locale":"es_ES","og_type":"article","og_title":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA","og_description":"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others","og_url":"https:\/\/www.cadca.org\/es\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","og_site_name":"CADCA","article_published_time":"2016-03-04T00:00:00+00:00","article_modified_time":"2024-04-24T19:50:22+00:00","og_image":[{"width":426,"height":320,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","type":"image\/jpeg"}],"author":"Marianne Varkiani","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Marianne Varkiani","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#article","isPartOf":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"},"author":{"name":"Marianne Varkiani","@id":"https:\/\/www.cadca.org\/#\/schema\/person\/8e6cb67aa13c20300a849b431c929dd2"},"headline":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis","datePublished":"2016-03-04T00:00:00+00:00","dateModified":"2024-04-24T19:50:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"},"wordCount":575,"image":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","keywords":["opioids"],"articleSection":["Public Health"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","url":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/","name":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage"},"image":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","datePublished":"2016-03-04T00:00:00+00:00","dateModified":"2024-04-24T19:50:22+00:00","author":{"@id":"https:\/\/www.cadca.org\/#\/schema\/person\/8e6cb67aa13c20300a849b431c929dd2"},"description":"CADCA represents over 5,000 community coalitions that involve individuals from key sectors including schools, law enforcement, youth, parents, healthcare, media, tribal communities and others","breadcrumb":{"@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#primaryimage","url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","contentUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cdc-us-overdose-deaths-2014_jr-1.jpg","width":426,"height":320},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/public-health\/eyewitness-report-fda-science-board-meets-on-opioid-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Eyewitness Report: FDA Science Board Meets on Opioid Crisis"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.cadca.org\/#\/schema\/person\/8e6cb67aa13c20300a849b431c929dd2","name":"Marianne Varkiani"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/posts\/18110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/comments?post=18110"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/posts\/18110\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/media\/2408"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/media?parent=18110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/categories?post=18110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/tags?post=18110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}